Skip to main content

Table 3 Summary of metabolites discriminating MetS

From: A molecular signature for the metabolic syndrome by urine metabolomics

Metabolite*

Variable importance in the model

log2FC

P-value

Associated RF

Glucose

1056.86

1.66 (1.37, 1.94)

5.88e−97

RF1, this study and definition

Formic acid

436.74

− 0.79 (− 0.87, − 0.71)

3.53e−77

n. a

Steroid lipids

364.47

0.57 (0.3, 0.86)

3.68e−31

RF3, this study and definition

TMAO§/1-Methyluric acid

218.32

− 0.54 (− 0.7, − 0.38)

1.58e−30

RF2 [47]

Trigonelline

201.66

− 0.4 (− 0.5, − 0.3)

1.38e−06

RF2 [48]

Tryptophan

198.95

− 0.38 (-0.44, − 0.31)

1.38e−38

RF2 [48]

Quinolinic acid

192.41

0.41 (0.24, 0.59)

1.99e−17

RF2 [36]

Imidazole

184.05

− 0.57 (− 0.7, − 0.43)

1.20e−26

RF4 [29]

Histidine

181.71

− 0.56 (− 0.75, − 0.37)

8.42e−16

RF4 [29]

4-HPPA§/p-cresol sulfate

171.38

0.53 (0.4, 0.67)

1.56e−19

RF1 [43]

Salicyluric acid

164.22

0.42 (0.29, 0.56)

8.77e−14

RF2 [48]

Maltitol

155.43

0.65 (0.45, 0.85)

2.22e−05

RF1 [28]

Methylhippuric acid

153.23

− 0.45 (− 0.54, − 0.36)

3.79e−21

n.a

Nicotinuric acid

146.41

− 0.38 (− 0.5, − 0.27)

1.18e−09

RF2 [48]

  1. n.a: not applicable
  2. *For metabolites with more than one associated bin, those results with the higher abs(log2FC) are showed
  3. Binary logarithms of fold-changes (log2FC), their 95% confidence intervals and p-values were calculated between MetS and non-MetS conditions
  4. Numbers in parentheses represent the bibliographic reference where this metabolite is related to the pertaining RF
  5. §4-HPPA: 4-hydroxyphenylpyruvic acid; TMAO: trimethylamine N-oxide